Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 13 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Use of LPA for encouraging pregnancy, and fertility agent
System and method for multi-tiered meta-data caching and distribution in a clustered computer environment
Dry-cooling unit with gravity-assisted coolant flow
Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
Soybean cultivar CL0911444
Method and system for delivering and executing virtual container on logical partition of target computing device
Control of protein activity using a conducting polymer
  Randomly Featured Patents
Method of measuring and preventing unstable feedback in hearing aids
Semiconductor apparatus and method for controlling the same
Method for making ceramic matrix composites using precursor polymers to refractory metal carbides and metal borides
Intake manifold
Vehicle air spring assembly
Combining separate infiniband subnets into virtual subnets
Method for gate electrode fabrication and symmetrical and non-symmetrical self-aligned inlay transistors made therefrom
Electronic apparatus
Process for extracting bitumen from tar sands
System and method for content aware in place translations in images